20-22 February 2017 the 10th ISBM Enclosed Conference was held. For ten years the employees annually have been meeting together to share their scientific results and talk over future plans. ISBM did a great job in this working year.
Seven big projects with international pharmaceutical companies were completed. Two research papers co-authored with colleagues from other organizations were published in PLOS Computational Biology and CPT: Pharmacometrics & Systems Pharmacology.
ISBM took part in 2 exhibitions and 4 important conferences, the employees presented their reports and posters on The International Liver Congress 2016, Population Approach Group in Europe 2016 Meeting (PAGE 2016), American Society for Clinical Pharmacology and Therapeutics 2016 Meeting (ASCPT 2016) and 6th American Conference on Pharmacometrics (ACoP6). And ISBM CEO, Oleg Demin, won the Quality Award for his oral presentation at the ACoP6.
We released an updated version of the Immune Response Template (IRT), a platform for Quantitative Systems Pharmacology modeling in the immune oncology field. It’s a big step for further QSP platform solutions development.
A new working year starts from the very important event – ASCPT 2017 Meeting. ISBM presents 8 posters and the IRT stand at the Exhibition. We will write about it in more details soon.
| ← | October 2024 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
|
2
|
3
|
4
1.
04 Oct 2024 16:13
InSysBio to participate in SITC 2024
InSysBio announces its participation in SITC’s 39th Annual Meeting which is to be held from November 6-10, 2024, at George R. Brown Convention Center in Houston, TX, USA. InSysBio team is going to present its Mechanistic modeling services and tools to support development of immunotherapies at Booth #1032 and 3 posters in frames of the Meeting
|
5
|
6
| |
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
|
14
|
15
|
16
1.
16 Oct 2024 19:36
InSysBio to take part in "An Introduction to QSP" event
InSysBio announces its participation in An Introduction to QSP, A UK QSP Network hybrid (in person/online) event which is to be held 17-20hrs 24th October 2024. Oleg Demin Jr, Scientific Director, Oncology & Immuno-Oncology, will discuss the prediction of the first-in-human dose for T-cell engagers using mechanistic modelling
|
17
|
18
|
19
|
20
|
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
|
28
|
29
|
30
|
31
| |||
Thank you for your message! We will get back to you shortly.
